» Articles » PMID: 17329210

LTP Inhibits LTD in the Hippocampus Via Regulation of GSK3beta

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2007 Mar 3
PMID 17329210
Citations 354
Authors
Affiliations
Soon will be listed here.
Abstract

Glycogen synthase kinase-3 (GSK3) has been implicated in major neurological disorders, but its role in normal neuronal function is largely unknown. Here we show that GSK3beta mediates an interaction between two major forms of synaptic plasticity in the brain, N-methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) and NMDA receptor-dependent long-term depression (LTD). In rat hippocampal slices, GSK3beta inhibitors block the induction of LTD. Furthermore, the activity of GSK3beta is enhanced during LTD via activation of PP1. Conversely, following the induction of LTP, there is inhibition of GSK3beta activity. This regulation of GSK3beta during LTP involves activation of NMDA receptors and the PI3K-Akt pathway and disrupts the ability of synapses to undergo LTD for up to 1 hr. We conclude that the regulation of GSK3beta activity provides a powerful mechanism to preserve information encoded during LTP from erasure by subsequent LTD, perhaps thereby permitting the initial consolidation of learnt information.

Citing Articles

Synaptic-dependent developmental dysconnectivity in 22q11.2 deletion syndrome.

Alvino F, Gini S, Minetti A, Pagani M, Sastre-Yague D, Barsotti N Sci Adv. 2025; 11(11):eadq2807.

PMID: 40073125 PMC: 11900866. DOI: 10.1126/sciadv.adq2807.


RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer's Disease.

Medd M, Yon J, Dong H Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996845 PMC: 11854763. DOI: 10.3390/cimb47020124.


Brain Plasticity and Cell Competition: Immediate Early Genes Are the Focus.

Tregub P, Komleva Y, Kukla M, Averchuk A, Vetchinova A, Rozanova N Cells. 2025; 14(2).

PMID: 39851571 PMC: 11763428. DOI: 10.3390/cells14020143.


NRF2, KEAP1 and GSK-3 levels in autism spectrum disorder: a case control study.

Subasi Turgut F, Karadag M, Taysi S, Hangul Z, Gokcen C Int J Dev Disabil. 2024; 70(8):1441-1451.

PMID: 39713511 PMC: 11660297. DOI: 10.1080/20473869.2023.2185959.


Harnessing the benefits of physical exercise-induced melatonin: a potential promising approach to combat Alzheimer's disease by targeting beta-amyloid (Aβ).

Bian R, Xiang L, Su Z Hormones (Athens). 2024; .

PMID: 39312178 DOI: 10.1007/s42000-024-00602-6.